Breaking News Instant updates and real-time market news.

ALNY

Alnylam

16:02
08/09/17
08/09
16:02
08/09/17
16:02

Alnylam expects to end FY17 with greater than $1.0B in cash and equivalents

Alnylam remains on track to end 2017 with greater than $1.0B in cash, cash equivalents and fixed marketable securities including $150.0M in restricted investments.

  • 09

    Aug

  • 09

    Aug

  • 23

    Aug

  • 07

    Sep

  • 12

    Sep

ALNY Alnylam

07/27/17
BERN
07/27/17
INITIATION
BERN
Outperform
Alnylam initiated with an Outperform at Bernstein
Bernstein analyst Vincent Chen started coverage of Alnylam with a $99 price target and an Outperform rating. He says that Alnylam " combines high-value late-stage assets with visible catalysts, and an increasingly de-risked RNA platform." The analyst adds that the company's assets are "high value and exciting," The analyst is upbeat on several of the company's late-stage therapies, including patisiran. He expects the latter therapy to obtain the "lion's share" of the TTR market.
07/17/17
LTCO
07/17/17
NO CHANGE
Target $90
LTCO
Buy
Alnylam price target raised to $90 from $80 at Ladenburg
Ladenburg Thalmann analyst Christopher James raised his price target for Alnylam Pharmaceuticals to $90 ahead of the upcoming Phase 3 APOLLO readout with patisiran. The analyst says his new target reflects increased confidence in a positive readout. He upped his probability of success for patisiran to 80% from 70% and keeps a Buy rating on Alnylam.
07/11/17
COWN
07/11/17
NO CHANGE
Target $325
COWN
Outperform
Shire hemophilia franchise being valued near zero, says Cowen
Cowen analyst Ken Cacciatore believes Shire's (SHPG) current valuation reflects essentially no value for the company's hemophilia franchise. Investors are treating Shire/Baxalta's hemophilia franchise as if it should equate to essentially zero, into perpetuity, beginning in 2020, Cacciatore tells investors in a research note, citing his analysis. He believes this sentiment, based on competitive concerns from Roche (RHHBY) and Alnylam (ALNY), is a "gross overreaction." The analyst has an Outperform rating on Shire with a $325 price target.
07/11/17
BMOC
07/11/17
NO CHANGE
BMOC
Alnylam weakness creates buying opportunity, says BMO Capital
BMO Capital analyst Do Kim says that the weakness of Alnylam's stock was caused by increases in ALT associated with the company's fitusiran drug. But the analyst says that such increases are "transient and asymptomatic," and Kim believes that the drug is superior to competing products. Kim recommends buying the stock on weakness.

TODAY'S FREE FLY STORIES

ESPR

Esperion

$44.74

-0.24 (-0.53%)

13:45
08/21/17
08/21
13:45
08/21/17
13:45
Hot Stocks
Breaking Hot Stocks news story on Esperion »

Meditor Group reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$18.12

-0.02 (-0.11%)

13:45
08/21/17
08/21
13:45
08/21/17
13:45
Options
KKR call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.44

0.805 (0.61%)

13:35
08/21/17
08/21
13:35
08/21/17
13:35
Periodicals
J&J must pay $417M in talc products trial, lawyers say, Reuters reports 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 05

    Sep

  • 06

    Sep

  • 22

    Sep

FJTSY

Fujitsu

$37.70

0.25 (0.67%)

, LNVGY

Lenovo

$11.52

-0.36 (-3.03%)

13:34
08/21/17
08/21
13:34
08/21/17
13:34
Periodicals
Fujitsu looking to sell mobile phone business, Nikkei reports »

Fujitsu's (FJTSY) is…

FJTSY

Fujitsu

$37.70

0.25 (0.67%)

LNVGY

Lenovo

$11.52

-0.36 (-3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ILMN

Illumina

$189.32

-1.88 (-0.98%)

13:25
08/21/17
08/21
13:25
08/21/17
13:25
Options
Illumina call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$83.85

0.441 (0.53%)

, COTY

Coty

$19.39

0.155 (0.81%)

13:23
08/21/17
08/21
13:23
08/21/17
13:23
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MDT

Medtronic

$83.85

0.441 (0.53%)

COTY

Coty

$19.39

0.155 (0.81%)

TOL

Toll Brothers

$38.29

0.14 (0.37%)

DSW

DSW

$15.74

-0.1 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 22

    Aug

  • 06

    Sep

  • 20

    Sep

ZAYO

Zayo Group

$32.88

-0.17 (-0.51%)

, NDSN

Nordson

$124.13

-1.37 (-1.09%)

13:22
08/21/17
08/21
13:22
08/21/17
13:22
Earnings
Notable companies reporting after market close »

Notable companies…

ZAYO

Zayo Group

$32.88

-0.17 (-0.51%)

NDSN

Nordson

$124.13

-1.37 (-1.09%)

PINC

Premier

$32.94

-0.15 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 06

    Sep

$NSD

NASDAQ Market Internals

13:17
08/21/17
08/21
13:17
08/21/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRZN

Horizon Technology

$10.27

-0.23 (-2.19%)

13:16
08/21/17
08/21
13:16
08/21/17
13:16
Upgrade
Horizon Technology rating change  »

Horizon Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
08/21/17
08/21
13:16
08/21/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$8.65

0.45 (5.49%)

13:15
08/21/17
08/21
13:15
08/21/17
13:15
Options
Sears put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$10.64

0.0763 (0.72%)

13:13
08/21/17
08/21
13:13
08/21/17
13:13
Periodicals
Union votes in favor of strike action at Ford Bridgend plant, Wales Online says »

The Unite union, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$32.31

-2.0701 (-6.02%)

13:11
08/21/17
08/21
13:11
08/21/17
13:11
Technical Analysis
Technical View: Foot Locker at new 52-week and multi-year lows »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CENX

Century Aluminum

$15.01

0.19 (1.28%)

13:09
08/21/17
08/21
13:09
08/21/17
13:09
Hot Stocks
Breaking Hot Stocks news story on Century Aluminum »

Balyasny Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOSBF

Toshiba, also use TOSYY

$2.69

-0.052 (-1.90%)

, TOSYY

Toshiba, also use TOSBF

$16.05

-0.32 (-1.95%)

13:08
08/21/17
08/21
13:08
08/21/17
13:08
Periodicals
Toshiba, Western Digital heads to seek compromise on memory unit, Nikkei says »

Western Digital (WDC) CEO…

TOSBF

Toshiba, also use TOSYY

$2.69

-0.052 (-1.90%)

TOSYY

Toshiba, also use TOSBF

$16.05

-0.32 (-1.95%)

WDC

Western Digital

$83.20

0.72 (0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCI

Johnson Controls

$37.86

0.81 (2.19%)

13:06
08/21/17
08/21
13:06
08/21/17
13:06
Recommendations
Johnson Controls analyst commentary  »

Johnson Controls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWL

Newell Brands

$48.44

-1.22 (-2.46%)

13:05
08/21/17
08/21
13:05
08/21/17
13:05
Options
Newell Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLAB

Mesa Labs

$129.98

-0.57 (-0.44%)

12:56
08/21/17
08/21
12:56
08/21/17
12:56
Hot Stocks
Mesa Labs director Stuart Campbell sells 2,000 shares »

Stuart Campbell, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

CSIQ

Canadian Solar

$16.63

0.23 (1.40%)

12:55
08/21/17
08/21
12:55
08/21/17
12:55
Options
Canadian Solar put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENRJ

EnerJex Resources

$0.28

-0.023 (-7.54%)

12:55
08/21/17
08/21
12:55
08/21/17
12:55
Hot Stocks
Breaking Hot Stocks news story on EnerJex Resources »

EnerJex Resources trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENRJ

EnerJex Resources

$0.28

-0.023 (-7.54%)

12:46
08/21/17
08/21
12:46
08/21/17
12:46
Hot Stocks
EnerJex Resources appoints Schleizer as interim CFO »

Effective August 17,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$8.11

-0.16 (-1.93%)

, AAPL

Apple

$157.50

-0.36 (-0.23%)

12:45
08/21/17
08/21
12:45
08/21/17
12:45
Periodicals
SEC reviewing Spotify's plan to skip IPO in NYSE listing, Bloomberg says »

Executives from music…

P

Pandora

$8.11

-0.16 (-1.93%)

AAPL

Apple

$157.50

-0.36 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 24

    Aug

  • 05

    Sep

COTY

Coty

$19.35

0.12 (0.62%)

12:45
08/21/17
08/21
12:45
08/21/17
12:45
Options
Coty call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

GPC

Genuine Parts

$82.19

0.59 (0.72%)

12:43
08/21/17
08/21
12:43
08/21/17
12:43
Hot Stocks
Genuine Parts elects Hardin as new independent director, adds 15M to repurchase »

Genuine Parts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

12:40
08/21/17
08/21
12:40
08/21/17
12:40
Hot Stocks
Icahn Automotive announces growth plans in Detroit »

Icahn Automotive Group, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.